Pamisell has ranked among the top searched stocks on 11 days in the past month.


As of 12:31 PM on the 22nd, Pamisell is trading at 18,700 KRW, down 3.36% from the previous day. This represents a 17.62% decline compared to August 26. Pamisell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.


Today, foreigners are tentatively recorded as net buyers of 21,000 shares. Over the past five days, individual investors have net purchased 144,471 shares, while foreigners and institutions have net sold 137,322 shares and 10,656 shares, respectively.





[Table] Net Buying and Selling Volume by Foreigners and Institutions (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing